錦欣生殖(01951.HK)低開後倒升半成 傳股東配股
市場有消息指,錦欣生殖(01951.HK)股東配售6,653.67萬股,每股配售價介乎10.58元至10.78元,較上日收市價11.16元,折讓3.41%至5.2%,套現7.04億元至7.17億元。
錦欣生殖市前有一宗6,650萬股以每股10.68元(較昨天收市價折讓4.3%)非自動對盤上板,涉資逾7.1億元。該股今早低開跌至10.96元獲承接,掉頭重越10天及20天線(11.2元及11.3元),最高見11.78元,現造11.72元,倒升5%,成交增至9,409萬股,涉資10.25億元。
瑞信本月初下調錦欣生殖目標價1.6%至14.88元,以反映因美國收入增速較預測低而下調集團2019-2021年盈測0.8%/2.6%/1.3%,但重申「跑贏大市」評級,以反映集團有清晰收購策略、在老撾新建人工受孕中心催化劑及穩固增長。(sz/a)~
阿思達克財經新聞
網址: www.aastocks.com
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.